Dissolvable Microneedle Patches for the Delivery of Cell-Culture-Derived Influenza Vaccine Antigens
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 101 (3) , 1021-1027
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Targeted, Needle‐Free Vaccinations in Skin using Multilayered, Densely‐Packed Dissolving Microprojection ArraysSmall, 2010
- Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicityJournal of Controlled Release, 2010
- Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adultsVaccine, 2009
- Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trialVaccine, 2009
- Transdermal drug deliveryNature Biotechnology, 2008
- A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccineVaccine, 2008
- Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery systemVaccine, 2007
- Novel Approaches to Vaccine DeliveryPharmaceutical Research, 2004
- InfluenzaThe Lancet, 2003
- Novel generations of influenza vaccinesVaccine, 2003